0001062993-21-004147.txt : 20210505 0001062993-21-004147.hdr.sgml : 20210505 20210505161708 ACCESSION NUMBER: 0001062993-21-004147 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210503 FILED AS OF DATE: 20210505 DATE AS OF CHANGE: 20210505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Looker Benjamin CENTRAL INDEX KEY: 0001859509 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36596 FILM NUMBER: 21893536 MAIL ADDRESS: STREET 1: C/O TRILLIUM THERAPEUTICS INC. STREET 2: 2488 DUNWIN DRIVE CITY: MISSISSAUGA STATE: A6 ZIP: L5L 1J9 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Trillium Therapeutics Inc. CENTRAL INDEX KEY: 0001616212 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2488 DUNWIN DRIVE CITY: MISSISSAUGA STATE: A6 ZIP: L5L 1J9 BUSINESS PHONE: (416) 595-0627 MAIL ADDRESS: STREET 1: 2488 DUNWIN DRIVE CITY: MISSISSAUGA STATE: A6 ZIP: L5L 1J9 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2021-05-03 0001616212 Trillium Therapeutics Inc. TRIL 0001859509 Looker Benjamin C/O TRILLIUM THERAPEUTICS INC. 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 ONTARIO, CANADA 0 1 0 0 General Counsel Stock Option (Right to Buy) 9.51 2021-05-03 4 A 0 190000 0 A 2031-05-03 Common Shares 190000 190000 D 25% of the options vest on the one year anniversary of the grant date and the remaining options vest in equal monthly installments over the following 36 months. /s/ James Parsons, Attorney-in-Fact 2021-05-05